Augmedix Inc
NASDAQ:AUGX
Augmedix Inc
NASDAQ:AUGX
Price:
3.76 USD
-1.31%
Market Closed
Updated:
Apr 16, 2024
Section:
Relative Value
The Relative Value of one
AUGX
stock under the Base Case scenario is
3.45
USD.
Compared to the current market price of 3.76 USD,
Augmedix Inc
is
Overvalued by 8%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
AUGX
Relative Value
Base Case
3.45
USD
Overvaluation 8%
Valuation Multiples
Multiples Across Competitors
AUGX Competitors Multiples
Augmedix Inc Competitors
Augmedix Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Augmedix Inc
NASDAQ:AUGX
|
182.8m USD | 4.1 | -9.5 | -8.6 | -8.1 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
32.5B USD | 13.7 | 61.8 | 61.6 | 66.2 | |
| US |
|
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 4.8 | 47.3 | 19.6 | 38.6 | |
| US |
|
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | 2.6 | -116.8 | 16.5 | 111.6 | |
| JP |
|
M3 Inc
TSE:2413
|
1.3T JPY | 5.5 | 28 | 14.9 | 16.8 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
10.7B AUD | 76 | 159.4 | 109.5 | 109.5 | |
| US |
|
Inspire Medical Systems Inc
NYSE:INSP
|
6.6B USD | 10.6 | -311.8 | -163.9 | -152.4 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.7B USD | 10.1 | 34.4 | 23.2 | 24.7 | |
| SE |
|
Sectra AB
STO:SECT B
|
40.5B SEK | 24.7 | 95.5 | -62.8 | -62.8 | |
| US |
|
Evolent Health Inc
NYSE:EVH
|
3.5B USD | 1.8 | -24.3 | 28.3 | 301.2 | |
| US |
|
Certara Inc
NASDAQ:CERT
|
2.8B USD | 7.9 | -50.4 | 45.6 | 457.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
